4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Cinchocaine.
Acepromazine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Aceprometazine.
Advertisement
Alfaxalone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Cinchocaine.
Alphaprodine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Alphaprodine.
Advertisement
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Cinchocaine.
Amisulpride
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cinchocaine.
Advertisement
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Cinchocaine.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Cinchocaine.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Cinchocaine.
Articaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Cinchocaine.
Azelastine
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Cinchocaine.
Barbital
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Benzyl alcohol.
Brexpiprazole
The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Cinchocaine.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Cinchocaine.
Bromperidol
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Cinchocaine.
Brotizolam
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Cinchocaine.
Buprenorphine
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Cinchocaine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Cinchocaine.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Cinchocaine.
Butamben
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cinchocaine.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cinchocaine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Cinchocaine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Cinchocaine.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Cinchocaine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Cinchocaine.
Chlormethiazole
The risk or severity of adverse effects can be increased when Cinchocaine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Cinchocaine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Cinchocaine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Cinchocaine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Cinchocaine.
Citalopram
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Cinchocaine.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Cinchocaine.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Cinchocaine.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Cinchocaine.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Cinchocaine.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Cinchocaine.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Cinchocaine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Cinchocaine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Cinchocaine.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Cinchocaine.
Cocaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Cinchocaine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Cinchocaine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Cinchocaine.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Cinchocaine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Cinchocaine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Cinchocaine.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Cinchocaine.
Dapiprazole
The risk or severity of adverse effects can be increased when Dapiprazole is combined with Cinchocaine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Cinchocaine.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Cinchocaine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Cinchocaine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Cinchocaine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Cinchocaine.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Cinchocaine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Cinchocaine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Cinchocaine.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Cinchocaine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Cinchocaine.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Cinchocaine.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Duloxetine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Cinchocaine.
Enflurane
The risk or severity of adverse effects can be increased when Enflurane is combined with Cinchocaine.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Cinchocaine.
Escitalopram
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Cinchocaine.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Cinchocaine.
Ethanol
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Cinchocaine.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Cinchocaine.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Cinchocaine.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Etomidate is combined with Cinchocaine.
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Cinchocaine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Cinchocaine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Cinchocaine.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Cinchocaine.
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Cinchocaine.
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Cinchocaine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Cinchocaine.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cinchocaine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Cinchocaine.
Fluspirilene
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Cinchocaine.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Cinchocaine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Cinchocaine.
Fospropofol
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Fospropofol.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Cinchocaine.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Cinchocaine.
Glutethimide
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Cinchocaine.
Halazepam
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Cinchocaine.
Halothane
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Hexobarbital.
Hyaluronidase
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Cinchocaine.
Hyaluronidase, Ovine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Cinchocaine.
Hydrocodone
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cinchocaine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Iloperidone
The risk or severity of adverse effects can be increased when Iloperidone is combined with Cinchocaine.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Cinchocaine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Cinchocaine.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Cinchocaine.
Ketazolam
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Cinchocaine.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Cinchocaine.
Levobupivacaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Cinchocaine.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Cinchocaine.
Levomethadyl
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Cinchocaine.
Lidocaine
The risk or severity of adverse effects can be increased when Lidocaine is combined with Cinchocaine.
Lithium
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Lithium.
Lofexidine
The therapeutic efficacy of Cinchocaine can be increased when used in combination with Lofexidine.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Cinchocaine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Cinchocaine.
Lormetazepam
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Cinchocaine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Cinchocaine.
Magnesium Sulfate
The therapeutic efficacy of Cinchocaine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Cinchocaine can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Cinchocaine.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Cinchocaine.
Melatonin
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Cinchocaine.
Mephobarbital
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Cinchocaine.
Mesoridazine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Cinchocaine.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Cinchocaine.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Cinchocaine.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Cinchocaine.
Methotrimeprazine
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Cinchocaine.
Metylperon
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Melperone.
Metyrosine
Cinchocaine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Cinchocaine.
Milnacipran
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Mirtazapine
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Cinchocaine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Cinchocaine.
Nefazodone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Cinchocaine.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Cinchocaine.
Nordazepam
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Cinchocaine.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Cinchocaine.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Cinchocaine.
Ondansetron
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Opium.
Orphenadrine
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Cinchocaine.
Oxprenolol
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Cinchocaine.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Cinchocaine.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Cinchocaine.
Paraldehyde
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Cinchocaine.
Paroxetine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Cinchocaine.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Cinchocaine.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Perazine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Cinchocaine.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Cinchocaine.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Phenoxyethanol.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Cinchocaine.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Cinchocaine.
Pipamperone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Cinchocaine.
Pirinitramide
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Pizotifen is combined with Cinchocaine.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cinchocaine.
Pramipexole
Cinchocaine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Cinchocaine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Prilocaine.
Primidone
The risk or severity of adverse effects can be increased when Primidone is combined with Cinchocaine.
Procaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Cinchocaine.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Cinchocaine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Cinchocaine.
Proparacaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Cinchocaine.
Propoxyphene
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Cinchocaine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Cinchocaine.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Cinchocaine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Cinchocaine.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Cinchocaine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Cinchocaine.
Remoxipride
The risk or severity of adverse effects can be increased when Remoxipride is combined with Cinchocaine.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Cinchocaine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Cinchocaine.
Ropinirole
Cinchocaine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Cinchocaine.
Rotigotine
Cinchocaine may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Cinchocaine.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Cinchocaine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Cinchocaine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Cinchocaine.
Sertindole
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Cinchocaine.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Cinchocaine.
Sulpiride
The risk or severity of adverse effects can be increased when Sulpiride is combined with Cinchocaine.
Suvorexant
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Cinchocaine.
technetium Tc 99m tilmanocept
Cinchocaine may decrease effectiveness of Technetium Tc-99m tilmanocept as a diagnostic agent.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Cinchocaine.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Cinchocaine.
Tetracaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Thalidomide
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Cinchocaine.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Cinchocaine.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Cinchocaine.
Tiapride
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Tiapride.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Cinchocaine.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Cinchocaine.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Cinchocaine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Cinchocaine.
Tranylcypromine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Cinchocaine.
Triazulenone
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Cinchocaine.
Triflupromazine
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Cinchocaine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Cinchocaine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Cinchocaine.
Urethane
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Cinchocaine.
Valproic Acid
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Cinchocaine.
Venlafaxine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Cinchocaine.
Vortioxetine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Cinchocaine.
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Cinchocaine.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Cinchocaine.
Zolpidem
Cinchocaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Cinchocaine.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Cinchocaine.
Zotepine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Cinchocaine.
